These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6634746)

  • 41. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW; Orr P; Kern DH
    Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current options in treatment of anthracycline-resistant breast cancer.
    Kröger N; Achterrath W; Hegewisch-Becker S; Mross K; Zander AR
    Cancer Treat Rev; 1999 Oct; 25(5):279-91. PubMed ID: 10544072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chromosomes and drug resistance of tumors].
    Levina NV
    Eksp Onkol; 1984; 6(2):14-9. PubMed ID: 6391904
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy update.
    Miaskowski C
    Nurs Clin North Am; 1991 Jun; 26(2):331-9. PubMed ID: 2047287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Cancer chemotherapy today and in the future].
    Tanneberger S
    Z Gesamte Inn Med; 1990 Dec; 45(23):693-5. PubMed ID: 2102024
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The present state of development of cancer chemotherapy.
    Ziegler JL
    Fed Proc; 1979 Jan; 38(1):97-102. PubMed ID: 365587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A qualitative approach to cell growth modeling and simulation for cancer chemotherapy.
    Gaglio S; Giacomini M; Nicolini C; Ruggiero C
    IEEE Trans Biomed Eng; 1991 Apr; 38(4):386-9. PubMed ID: 1855803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commonly used chemotherapeutic agents.
    Carter BL
    Prim Care; 1987 Jun; 14(2):293-315. PubMed ID: 3299425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.
    Goldie JH; Coldman AJ
    Cancer Treat Rep; 1979; 63(11-12):1727-33. PubMed ID: 526911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concepts for the treatment of tumor metastasis.
    Griswold DP; Schabel FM; Dykes DJ; Trader MW; Laster WR
    Symp Fundam Cancer Res; 1983; 36():389-96. PubMed ID: 6382515
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immunological aspects of resistance to antineoplastic chemotherapy].
    D'Alessandro N
    Clin Ter; 1991 Jul; 138(1):37-44. PubMed ID: 1834399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer chemotherapy: a critical analysis of its 60 years of history.
    Galmarini D; Galmarini CM; Galmarini FC
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):181-99. PubMed ID: 22542531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Chemoresistance of tumors. Factors related to tumor kinetics and the occurrence of resistant cells].
    Tubiana M
    Bull Cancer; 1989; 76(9):959-65. PubMed ID: 2695184
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical aspects of drug resistance.
    Sobrero A; Bertino JR
    Cancer Surv; 1986; 5(1):93-107. PubMed ID: 3297314
    [No Abstract]   [Full Text] [Related]  

  • 57. Cancer chemotherapy 1990.
    Bagshawe KD
    Trans Med Soc Lond; 1989-1990; 106():42-50. PubMed ID: 2562620
    [No Abstract]   [Full Text] [Related]  

  • 58. Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency.
    Harnevo LE; Agur Z
    Cancer Chemother Pharmacol; 1992; 30(6):469-76. PubMed ID: 1394803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Why does cytotoxic chemotherapy cure only some cancers?
    Savage P; Stebbing J; Bower M; Crook T
    Nat Clin Pract Oncol; 2009 Jan; 6(1):43-52. PubMed ID: 18982000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical observations on chemotherapy curable malignancies: unique genetic events, frozen development and enduring apoptotic potential.
    Savage P
    BMC Cancer; 2015 Jan; 15():11. PubMed ID: 25605631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.